What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
Top Cited Papers
- 28 August 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 69 (9) , 871-877
- https://doi.org/10.1212/01.wnl.0000269790.05105.16
Abstract
Background: Few studies have compared the accuracy of [18F]fluorodeoxyglucose (FDG) PET to the accuracy of clinical and pathologic diagnosis in dementia patients.Keywords
This publication has 24 references indexed in Scilit:
- Brain imaging evidence of preclinical Alzheimer's disease in normal agingAnnals of Neurology, 2006
- A comparison of classification methods for differentiating fronto‐temporal dementia from Alzheimer's disease using FDG‐PET imagingStatistics in Medicine, 2004
- Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PETMolecular Genetics and Metabolism, 2003
- PET studies in dementiaAnnals of Nuclear Medicine, 2003
- Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's diseaseAnnals of Neurology, 1997
- Frequency of hippocampal formation atrophy in normal aging and Alzheimer's diseaseNeurobiology of Aging, 1997
- Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- The Clinical Dementia Rating (CDR)Neurology, 1993
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- “Mini-mental state”Journal of Psychiatric Research, 1975